Search

everythinglearnresearchcommunity

for

Search:↓

The study found that a specific genetic variation in the TNFα gene is significantly linked to Alopecia Areata in the Jordanian Arab population.

A 78-year-old man with Cronkhite-Canada syndrome improved significantly after treatment and remains symptom-free.

A gene mutation causes monilethrix in a Chinese family.

The environment around the time of conception can change the VTRNA2-1 gene in a way that lasts for years and may affect disease risk.

A genetic mutation in the CDH3 gene causes hair loss and vision problems in a young Saudi girl.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.

A new gene mutation linked to Olmsted syndrome may increase cancer risk, suggesting the need for ongoing patient monitoring.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

Cronkhite-Canada syndrome can cause multiple gastrointestinal polyps and various physical symptoms.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Noncoding RNAs help determine cashmere quality in goats.

Truncating mutations in the C2orf37 gene cause Woodhouse–Sakati syndrome.

A child with ectodermal dysplasia-syndactyly syndrome has a new mutation in the NECTIN4 gene.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

CT60 polymorphism might increase the risk of Alopecia Areata.

Inflammation may cause nail issues in Cronkhite–Canada Syndrome.

A woman with a rare hormone resistance condition also had missing teeth and hair loss, which might be new symptoms of her genetic disorder.

Genetic differences affect COVID-19 severity and treatment development.

A single amino acid change in the vitamin D receptor can disrupt its function and lead to hair loss.

The man was diagnosed with Cronkhite-Canada syndrome, a rare disorder with GI polyps, skin issues, hair loss, and nail problems.

Enteral supplements can improve symptoms of Cronkhite-Canada syndrome.

Certain variations of the HDAC9 gene can increase or decrease stroke risk in the Chinese population.

PRSS35 enzyme may help start skin tumors and could be a target for cancer treatment.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

Cronkhite-Canada Syndrome often leads to death within 6-18 months.

Men with more CAG repeats in the androgen receptor gene and lower testosterone levels may experience more severe COVID-19.

A gene in Sebekia benihana, CYP-sb21, is needed for a specific reaction on the drug Cyclosporine A, which could be important for hair growth without affecting the immune system.